Bioplatforms Australia News

New publication – Unexpected discovery behind second Devil facial tumour

 

A new publication from lead author Dr Amanda Patchett of the University of Tasmania’s Menzies Institute for Medical Research describes the unexpected discovery on the origin of the second transmissible facial Devil facial tumour disease (DFT2). The article is out in Cellular and Molecular Life Sciences.

The research was performed by scientists from the University of Tasmania’s Menzies Institute for Medical Research, School of Medicine and Central Science Laboratory, with support from the University of Cambridge, Australian Proteome Analysis Facility and Walter and Eliza Hall Institute of Medical Research.

Funding for the study was provided by the Australian Research Council, with additional support from the University of Tasmania Foundation through funds raised by the Save the Tasmanian Devil Appeal, the Australian Government’s National Collaborative Research Infrastructure Scheme and a joint research initiative between the University of Tasmania and Bioplatforms Australia.

 

The full media release from the University of Tasmania can be found here 

 

Contact:
Andrew Gilbert | agilbert@bioplatforms.com

Synthetic Biology Scoping

Full media release here

News and Media

Latest Bioplatforms News and Media

News Signup

Bioplatforms Australia

+61 0410 538 648

agilbert@bioplatforms.com